[6-oxo-3-(2-thienyl)pyridazin-1(6{H})-yl]acetic acid, 95.0%, 1g

2-Bromo-4-chlorobenzotrifluoride, 96.0%, 10g

tert-Butyl (4-(piperidin-4-yloxy)phenyl)carbamate, 95%, 1g

3-IODOPYRAZOLO[1,5-A]PYRIDINE, 97.0%, 5g

3-(Benzyloxy)-5-fluoroaniline, 95+%, 250mg

4-Chloro-2-(4-oxopiperidin-1-yl)thiazole-5-carbaldehyde, 95.0%, 5g

2-(2-(2-(2-((Tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 97%, 500mg

4-FLUORO-3-(TRIFLUOROMETHYL)PHENYLHYDRAZINE HCL, 95%, 5g

3-Bromo-4-fluorothiophenol, 95.0%, 5g

3-BROMO-N-METHOXY-N-METHYL-PROPIONAMIDE, 95.0%, 250mg

Cuvette d'échantillon Type 2117, 1000 ml, 4 pièce(s)

7-Chloro-2,3-dihydroquinolin-4(1H)-one, 95.0%, 5g

Récipients de réactifs 175 ml sans couvercle, non stériles, 10 x 10, 100 pièces